Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc Opts To Sell Off Lucozade And Ribena Drink Brands-Reuters


Wednesday, 24 Apr 2013 07:19am EDT 

Reuters reported that Glaxosmithkline Plc has decided to sell its soft drink brands Lucozade and Ribena in a disposal that analysts believe could bring in more than GBP1 billion ($1.5 billion).